SUBIACO-BASED drug discovery firm Phylogica has announced an agreement with Europe’s largest pharmaceutical company, Roche, to evaluate the firm’s disease-attacking technology.

SUBIACO-BASED drug discovery firm Phylogica has announced an agreement with Europe’s largest pharmaceutical company, Roche, to evaluate the firm’s disease-attacking technology.